dr hu on choosing between bispecific antibodies vs car t-cell therapy in dlbcl
Published 3 months ago • 64 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
4:01
what are the differences between car t-cell therapy and bispecific antibodies?
-
1:04
bispecifics & car-t therapy in dlbcl: sequencing and selecting between these agents
-
1:44
bispecific antibodies vs car-t cells in dlbcl: the benefit of car-t therapy
-
2:52
current immunotherapeutic approaches in dlbcl: the value of car-t cells and bispecific antibodies
-
8:31
how to decide between bispecific antibodies or car t-cell therapies
-
12:15
car-t vs bispecific antibodies for lymphoma
-
1:23
advantages of bispecific antibodies over car-t therapy in lbcl
-
1:14
the car t-cell strategy vs bispecific antibodies
-
4:35
bispecific antibodies vs car t-cells for r/r multiple myeloma
-
2:34
car-t & bispecific antibodies in second-line dlbcl
-
6:23
the benefits of bispecific antibodies over car-t cell therapy in lymphoma
-
3:12
what are the pros and cons of car t-cell therapy vs. bispecific antibodies? - blood cancer onctalk
-
0:48
dr. tzachanis on the likelihood of cure with car t-cell therapy in lymphoma
-
1:40
current & future outlooks on car-t therapy & bispecific antibodies in follicular lymphoma
-
4:27
the possibility of combining car-t therapy and bispecific antibodies in the treatment of nhl
-
2:38
weighing up the pros and cons of car-t therapy and bispecific antibodies in r/r dlbcl
-
6:59
will bispecific antibodies challenge car t-cell therapy in follicular lymphoma? - medpage today
-
1:25
moving car t-cell therapy and bispecific antibodies in the consolidation setting
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma